Intuitive Surgical reports 22% revenue growth and $450 million settlement charge
Filed with the SEC on · Summarized by InvestorsBot
Intuitive Surgical reported third-quarter 2026 revenue of $3.05 billion, up 22% from $2.51 billion a year earlier, while worldwide da Vinci and Ion procedures grew about 15% and non-GAAP diluted EPS rose to $3.00 from $2.40. GAAP diluted EPS fell to $1.49 from $1.95 after the company recorded a $450 million pre-tax charge for an antitrust litigation settlement reached in October, which remains subject to court approval; Intuitive also repurchased $2.94 billion of stock and reaffirmed its 2026 outlook, including 14% to 15% da Vinci procedure growth.